The American Psychiatric Association recently voted to drop its old recommendation against diagnosing depression in the bereaved, which the Washington Post noted could be a financial bonanza for antidepressant manufacturers.
But according to an investigation by the Post, the committee that drafted the new diagnostic guidelines was composed largely of people with financial links to the pharmaceutical industry.
A story in the Post says officials with the Institute of Medicine argue that ...
continue reading...
A story in U.K. newspaper The Mirror concerns the higher risk of “third-generation” contraceptive pills, compared to ones that have been on the market for longer.
The U.S. Food and Drug Administration has approved Skyla, an intrauterine device manufactured by Bayer.
